Dec 19, 2024 · Neurosense is finalizing the protocol of a Phase 3 study of PrimeC for ALS, and plans to submit the protocol for FDA approval by mid-2025.

Dec 30, 2024 · News stories about clinical trials testing potential treatments were among the top 10 most-read articles on ALS News Today in 2024.

Nov 20, 2024 · A newly awarded grant from the ALS Association will support Asha Therapeutics' work to advance ASHA-624 into a first-in-human clinical trial.

6 days ago · Finding new equipment for ALS management feels like a win For more than a decade living with my husband Todd’s ALS, I’ve been the finder and procurer of equipment …

Dec 27, 2024 · Sharing ALS updates with others is a personal choice. Columnist Juliet Taylor explains how she and her late husband decided to communicate.

Dec 20, 2024 · The HEALEY ALS platform trial, which is simultaneously testing multiple potential treatments for amyotrophic lateral sclerosis (ALS), is amending its master protocol to allow a …

Dec 2, 2024 · The Phase 1 trial ANQUR, now testing two new doses of the ALS therapy QRL-201, is enrolling patients at 12 sites in Canada and across Europe.

Nov 15, 2024 · Trace Neuroscience kicked off its operations in California with $101 million in Series A financing, which the company will use to continue developing its lead treatment …

Sep 11, 2024 · AcuraStem has received $4 million in funding from the California Institute for Regenerative Medicine (CIRM) to advance the development of AS-241, an investigational …

Nov 6, 2024 · Leal Therapeutics raised $45 million for drug development, including advancing a promising therapy into clinical trials for ALS.